A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 Capsules
Clinical trial NCT06224595 · COMPLETED
Trial details
- NCT number
- NCT06224595
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2024-11-27
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.